Most Recent
Settlement attempts in GetSwift class action like flogging a dead horse, court hears
Further attempts to settle a securities class action against last mile logistics software firm GetSwift would be like flogging a dead horse, a judge has heard as the matter works its way towards a final hearing.
Law firm can’t delay appeal over unpaid bill because QC won’t fly without vaccine
Law firm Atanaskovic Hartnell has failed to postpone its appeal of a ruling over unpaid legal fees until after its senior counsel -- who is stuck in London -- can get a COVID-19 vaccine and return to Australia.
CBA cops to misleading customers on more than 12,000 occasions
Commonwealth Bank of Australia could be on the hook for a large penalty after the court found the bank engaged in misleading and deceptive conduct and violated its financial services obligations on more than 12,000 occasions by overcharging customers more than $2.2 million in interest.
Tax adviser hit with record $22.7M fine over R&D tax scheme
A tax agent and accountant who conducted multiple tax exploitation schemes between 2011 and 2015 has been hit with a $22.7 million penalty, the largest ever against a tax promotor.
PwC takes swipe at class action over $50M bond prospectus
PricewaterhouseCoopers is looking to shut down a class action by irate bondholders of collapsed asset finance lender Axsesstoday Limited over alleged misrepresentations in a $50 million bond offer.
Full Court hears government’s $325M fight with Sanofi over ban on Plavix generic
Pharmaceutical companies Sanofi and Bristol-Myers Squibb are liable for losses to the federal government for excess subsidies it allegedly paid for the blood-thinner Plavix after an unjustified court injunction prevented the release of a generic version of the top-selling drug, an appeals court has heard.
$37.75M settlement reached in Estia Health class action
A $37.75 million settlement has been reached in a shareholder class action against Estia Health that accused the aged care provider of failing to disclose difficulties in its 2015 and 2016 acquisition strategy.
Merck Sharpe & Dohme sues Sandoz to block Januvia generic
US pharmaceutical giant Merck Sharp & Dohme has taken Sandoz to court for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Janumet and Januvia.
GetSwift slammed for ‘unfair attack’ on judge hearing class action, ASIC case
GetSwift has been criticised for its "quite unfair attack" on a Federal Court judge who refused to disqualify himself from hearing a shareholder class action against the logistics software company after presiding over ASIC's civil penalty proceeding against the company.
Hyundai faces class action investigation over recalled cars
South Korean car maker Hyundai is facing a possible class action after it recalled over 90,000 cars earlier this month over safety concerns.